CLINICAL_TRIALS
withdrawal
· 2016-08-08
Clinical Trial Update: A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT) [Phase 2]
Summary
A Phase II study evaluating low-dose fractionated radiotherapy for squamous cell carcinoma of the head and neck has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Arkansas | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 2 | Status: WITHDRAWN